CNR1 and Alzheimer disease: Furthermore, depending on the severity of AD, CB1R at an early stage of neurodegeneration improves cognitive function by inhibition of apoptosis and gliosis, whereas at a later stage of the diseases, it promotes Aβ induced loss probably by blocking residual activity as suggested previously [360].